Publicaciones científicas sobre los diagnósticos no invasivos de BioPredictive

Estudios revisados por pares que validan los diagnósticos por análisis de sangre de BioPredictive para enfermedades hepáticas — desde cohortes de desarrollo pioneras hasta metaanálisis a largo plazo.

8/435 Coincidencias para
“chronic obstructive pulmonary disease”

“chronic obstructive pulmonary disease” Borrar todo

  1. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.

    Viglino D et al. · Eur Respir J · 2017 Coinc. 100

    …fat, common features of chronic obstructive pulmonary disease (COPD), might contribute to…

    FibroTest NashTest SteatoTest Metabolic

  2. Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease.

    Viglino D et al. · Sci Rep · 2018 Coinc. 94

    Chronic Obstructive Pulmonary Disease (COPD) and Non-Alcoholic Fatty Liver Disease (NAFLD…

    FibroTest NashTest SteatoTest Metabolic

  3. Fibromax-based nonalcoholic fatty liver disease in chronic obstructive pulmonary disease patients with obstructive sleep apnea: Methodological considerations.

    Monneret D · F1000Res · 2017 Coinc. 88

    …to be evidenced in chronic obstructive pulmonary disease (COPD). Recently, Viglino _et…

    FibroTest NashTest SteatoTest Metabolic

  4. Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.

    Natarajan Y et al. · Dig Dis Sci · 2017 Coinc. 82

    …determinants of mortality in many chronic diseases. The extent to which survival…

    FibroTest HCV

  5. Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia.

    Poynard T et al. · Hepatol Commun · 2023 Coinc. 75

    FibroTest Other

  6. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.

    Sadler MD et al. · Can J Gastroenterol Hepatol · 2015 Coinc. 69

    ### Background Liver disease is the third leading cause of mortality in patients…

    FibroTest Other

  7. Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19. Key publication

    Deckmyn O et al. · Biomedicines · 2022 Coinc. 63

    In patients with non-alcoholic fatty liver disease (NAFLD) with or without…

    FibroTest Metabolic

  8. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication

    · 2014 Coinc. 57

    These are the first guidelines dealing with hepatitis C treatment produced by…

    FibroTest HCV

Mostrando la lista completa de resultados. La página se renderiza en el servidor y no está paginada.